The Term Auction Facility may be the most interesting of the new data dumps, because this program was designed to remove discount window stigma: Bank funding markets, especially term funding markets, ...
-- Improved Markers of Bone and Renal Safety Also Seen with TAF in Separate Analysis of HBV Patients with Hepatic or Renal Impairment -- -- Data on Investigational TLR8 Agonist GS-9688 Support ...
Gilead Sciences Inc. GILD announced positive data from a phase III study on fixed-dose combinations of Emtriva (emtricitabine) and tenofoviralafenamide/TAF (200/10 mg and 200/25 mg) for the treatment ...
ViiV Healthcare presents long-term switch data for Dovato demonstrating non-inferior efficacy in adults with HIV-1 and zero cases of virologic failure versus continuation of a 3-drug TAF-based regimen ...
A key opinion leader reviews findings presented at ID Week 2020 from a post-hoc analysis of the AMBER study comparing GI tolerability of D/C/F/TAF to TDF. Moti Ramgopal, MD, FACP, FIDSA, CPI: The ...
Gilead Sciences Inc (NASDAQ: GILD) announced long-term Biktarvy (bictegravir 50 mg/emtricitabine 200 mg/tenofovir alafenamide 25 mg tablets, B/F/TAF) data showing high efficacy and durable viral ...
The NOAA Aviation Weather Center provides free, accessible weather information globally, including TAFs (terminal area forecasts) and METARs (meteorological aerodrome reports). To find weather ...
ViiV Healthcare, the global specialist HIV company majority owned by GlaxoSmithKline plc (“GSK”), with Pfizer Inc. and Shionogi Limited as shareholders, today presented three-year results from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback